Ngā hua rapu - Ingeborg Taksdal
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
Chondrosarcoma in Norway 1990–2013; an epidemiological and prognostic observational study of a complete national cohort mā Joachim Thorkildsen, Ingeborg Taksdal, Bodil Bjerkehagen, Hans Kristian Haugland, Tom Børge Johannesen, Trond Viset, Ole-Jacob Norum, Øyvind S. Bruland, Olga Zaikova
I whakaputaina 2019Artigo -
2
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial mā Kjetil Boye, Alessandra Longhi, Tormod Kyrre Guren, Susanne Lorenz, Stine Næss, Michela Pierini, Ingeborg Taksdal, Ingvild Lobmaier, Marilena Cesari, Anna Paioli, Ayca Muftuler Løndalen, Elisabetta Setola, Ivar Hompland, Leonardo A. Meza‐Zepeda, Kirsten Sundby Hall, Emanuela Palmerini
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Internal medicine
Medicine
Surgery
Cancer registry
Chondrosarcoma
Clinical trial
Cohort
Cohort study
Epidemiology
Immunotherapy
Incidence (geometry)
Malignancy
Observational study
Oncology
Open label
Optics
Osteosarcoma
Pathology
Pembrolizumab
Physics
Radiological weapon
Retrospective cohort study